This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Founded in 1846 and based in Ewing, NJ , Church & Dwight Co., Inc. develops, manufactures and markets a broad range of household, personal care and specialty products. It is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda, a natural product that cleans, deodorized, leavens and buffers. The company operates in six countries (Canada, Mexico, U.K., France, Australia and Brazil) and exports to over 90 other countries. Approximately 17% of the company’s net sales came from outside the U.S. in 2019. The company has 12 key brands, including ARM & HAMMER, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, Xtra, L’IL CRITTERS and VITAFUSION, Waterpik, FLAWLESS and Batiste. The company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products and its products are sold under ARM & HAMMER liquid and powder laundry detergent, ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER baking soda. Markedly, eleven out twelve power brands were acquired by the company and added to its portfolio since 2001.
Factors Likely to Decide Newell's (NWL) Fate in Q3 Earnings
by Zacks Equity Research
Newell's (NWL) third-quarter results are expected to reflect gains from innovation, e-commerce and cost savings. However, lower core sales and adverse currency might have been drags.
Should You Buy Church & Dwight (CHD) Ahead of Earnings?
by Zacks Equity Research
Church & Dwight (CHD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Things You Need to Know Before Colgate's (CL) Q3 Earnings
by Zacks Equity Research
Higher raw material and SG&A costs, and adverse currency are likely to get reflected in Colgate's (CL) third-quarter margins and earnings. However, pricing gains and innovation might have offset woes.
Here's How Kraft Heinz (KHC) Looks Ahead of Q3 Earnings
by Zacks Equity Research
The Kraft Heinz Company's (KHC) third-quarter 2019 results are expected to reflect impacts from retailer inventory reductions and cost inflation.
Things You Should Know Prior to Avon's (AVP) Q3 Earnings
by Zacks Equity Research
Avon's (AVP) Open Up strategy is likely to have driven performance in third-quarter 2019. However, its Europe, Middle East & Africa segment, and adverse currency are likely to have been deterrents.
Church & Dwight (CHD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hershey (HSY) Q3 Earnings In Line With Estimates, Sales Up
by Zacks Equity Research
Hershey's (HSY) Q3 results benefit from improved volumes and acquisitions. However, currency rates were a drag during the quarter.
Factors Likely to Decide Molson Coors' (TAP) Fate in Q3 Earnings
by Zacks Equity Research
Soft volume, higher marketing expenses and input costs are likely to reflect on Molson Coors' (TAP) third-quarter 2019 results. Also, strong global pricing and innovation may offset headwinds.
Factors Shaping the Fate of Estee Lauder's (EL) Q1 Earnings
by Zacks Equity Research
Estee Lauder's (EL) first-quarter fiscal 2020 results are expected to reflect solid skincare sales along with strength in travel retail and online networks.
What's in Store for Service Corporation's (SCI) Q3 Earnings?
by Zacks Equity Research
Service Corporation International's (SCI) third-quarter 2019 results are expected to reflect impacts from efforts to drive preneed sales, an aging baby boomer population and higher funeral segment profit.
Factors Setting the Tone for Clorox's (CLX) Q1 Earnings
by Zacks Equity Research
Softness in Charcoal, and Bags and Wraps businesses is likely to have impacted Clorox (CLX) Q1 performance. High cost and unfavorable currency impacts are deterrents.
Procter & Gamble (PG) Stock Rises on Q1 Earnings & Sales Beat
by Zacks Equity Research
Procter & Gamble's (PG) sales and earnings beat estimates in Q1 on organic sales growth in all segments, margin expansion and cash productivity gains. It raises view for fiscal 2020.
Factors Setting the Tone for Mondelez's (MDLZ) Q3 Earnings
by Zacks Equity Research
Benefits from strong brands in the snacking arena are likely to shown on Mondelez's (MDLZ) Q3 performance. However, high input costs and adverse currency rates are concerns.
4 Winning Consumer Staples Stock Bets for This Earnings Season
by Rajani Lohia
Efforts to boost productivity, improved pricing and marketing initiatives may have aided Consumer Staples companies in the September quarter, while high costs and macro factors are likely to have hurt.
Looking for a Growth Stock? 3 Reasons Why Church & Dwight (CHD) is a Solid Choice
by Zacks Equity Research
Church & Dwight (CHD) could produce exceptional returns because of its solid growth attributes.
Can Procter & Gamble (PG) Beat on Earnings Again in Q1?
by Zacks Equity Research
Procter & Gamble (PG) is likely to have witnessed positive trends in first-quarter fiscal 2020 on growth initiatives, including innovation, packaging and marketing efforts.
Coca-Cola (KO) to Report Q3 Earnings: What Should You Expect?
by Zacks Equity Research
Cola-Cola (KO) gains from the acceleration of sparkling soft drink category through investment and innovation. Further, its productivity and reinvestment program should drive growth.
Why Church & Dwight (CHD) Could Beat Earnings Estimates Again
by Zacks Equity Research
Church & Dwight (CHD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Top Ranked Growth Stocks to Buy for October 7th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, October 7th
Clorox (CLX) Introduces IGNITE Strategy, Trims FY20 Guidance
by Zacks Equity Research
Clorox (CLX) introduces IGNITE strategy, which is built on a sturdy foundation of its 2020 Strategy. It aims to innovate in all areas of the business. However, management lowers view for fiscal 2020.
Nu Skin's Customer Base Bodes Well, Mainland China is a Worry
by Zacks Equity Research
Nu Skin (NUS) is battling headwinds in Mainland China that led to an unimpressive view for 2019. However, a rising customer base bodes well.
Should You Invest in the Invesco DWA Consumer Staples Momentum ETF (PSL)?
by Zacks Equity Research
Sector ETF report for PSL
Lamb Weston (LW) Earnings Miss in Q1, Sales Improve Y/Y
by Zacks Equity Research
Lamb Weston's (LW) Q1 earnings and sales increase year over year, backed by improved volumes and price/mix across segments.
Church & Dwight up 9.2% in 6 Months, Strong Brands Add Gleam
by Zacks Equity Research
Church & Dwight's (CHD) robust brand portfolio is boosting market share across categories. However, weakness in the Specialty Products unit is a worry.
Colgate (CL) Displays a Solid Run-Up of More Than 20% YTD
by Zacks Equity Research
Colgate (CL) is benefiting from higher pricing, strong innovation and expansion efforts. Moreover, the company's savings programs are delivering impressive result.